Development of a Novel Anti-Siglec-15 Antibody for Tumor Immunotherapy

ImmunoTargets and Therapy · Published 2025-12-01 · DOI 10.2147/itt.s536009

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.2147/itt.s536009

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Induction Chemotherapy Followed by Immunotherapy Increases Pathological Complete Response Rate in dMMR/MSI-H Gastric Cancer: A Retrospective Cohort Study · ImmunoTargets and Therapy · 2026 · Same journal
• Deep Learning Classification of Rheumatoid Arthritis in Hand Radiographs Interpretability Insights and Web Application · ImmunoTargets and Therapy · 2025 · Same journal
• TLR9: A Double-Dealing Toll-Like Receptor · ImmunoTargets and Therapy · 2025 · Same journal
• Inhibitors of KAT2A Alleviate the Progression of AKI by Alleviating Macrophage Ferritinophagy · ImmunoTargets and Therapy · 2025 · Same journal
• Guillain-Barré Syndrome: Progress in Diagnosis, Biomarkers, Neuroimaging and Management · ImmunoTargets and Therapy · 2026 · Same journal
• Circulating miR-148a-3p Correlates with Inadequate Induction Response in Pediatric Hodgkin Lymphoma · ImmunoTargets and Therapy · 2026 · Same journal
• Near Infrared Photoimmunotherapy for Lung Cancer: Recent Development and Perspective · ImmunoTargets and Therapy · 2026 · Same journal
• RNA Sequencing Analyses and Validation of Immune-Related Genes in EBV-Specific Cytotoxic T Lymphocytes During Latent Infection · ImmunoTargets and Therapy · 2026 · Same journal
• Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune Disorders · ImmunoTargets and Therapy · 2026 · Same journal
• Lymphoproliferation in Inborn Errors of Immunity: Mechanisms, Manifestations and Clinical Management, with a Focus on ALPID · ImmunoTargets and Therapy · 2026 · Same journal